 |
monomethoxypolyethylene glycol recombinant adenosine deaminase |
|---|---|
| Trade Name | |
| Orphan Indication | Systemic scleroderma |
| USA Market Approval | USA |
| USA Designation Date | 2017-06-15 00:00:00 |
| Sponsor | Leadiant Biosciences, Inc.;9841 Washingtonian Boulevard, Suite 500;Gaithersburg, Maryland, 20878 |
